Bath Savings Trust Co cut its holdings in Accenture PLC (NYSE:ACN – Free Report) by 17.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,966 shares of the information technology services provider’s stock after selling 3,425 shares during the period. Bath Savings Trust Co’s holdings in Accenture were worth $3,937,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the business. Investors Research Corp lifted its position in Accenture by 73.8% during the 3rd quarter. Investors Research Corp now owns 106 shares of the information technology services provider’s stock worth $26,000 after buying an additional 45 shares in the last quarter. Kelly Lawrence W & Associates Inc. CA acquired a new stake in shares of Accenture in the first quarter valued at about $31,000. Heartwood Wealth Advisors LLC bought a new stake in Accenture during the third quarter worth about $32,000. RMG Wealth Management LLC acquired a new position in Accenture during the second quarter valued at approximately $33,000. Finally, Howard Hughes Medical Institute acquired a new position in shares of Accenture during the 2nd quarter worth approximately $40,000. Institutional investors and hedge funds own 75.14% of the company’s stock.
Accenture Stock Down 1.4%
Shares of ACN opened at $269.84 on Friday. The firm has a market cap of $177.68 billion, a P/E ratio of 22.21, a price-to-earnings-growth ratio of 2.66 and a beta of 1.26. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.42 and a current ratio of 1.42. Accenture PLC has a 52 week low of $229.40 and a 52 week high of $398.35. The firm’s 50-day simple moving average is $252.18 and its 200 day simple moving average is $264.34.
Accenture Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Tuesday, January 13th will be issued a dividend of $1.63 per share. The ex-dividend date of this dividend is Tuesday, January 13th. This represents a $6.52 dividend on an annualized basis and a dividend yield of 2.4%. Accenture’s dividend payout ratio (DPR) is currently 53.66%.
Insider Activity
In related news, CEO Ryoji Sekido sold 2,500 shares of the company’s stock in a transaction dated Wednesday, October 22nd. The shares were sold at an average price of $249.47, for a total value of $623,675.00. Following the transaction, the chief executive officer directly owned 1,390 shares in the company, valued at approximately $346,763.30. This represents a 64.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Julie Spellman Sweet sold 5,917 shares of Accenture stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $246.62, for a total transaction of $1,459,250.54. Following the completion of the sale, the chief executive officer owned 8,599 shares of the company’s stock, valued at $2,120,685.38. This trade represents a 40.76% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 33,319 shares of company stock valued at $8,335,225. 0.02% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the company. JPMorgan Chase & Co. cut their price objective on Accenture from $302.00 to $290.00 and set an “overweight” rating for the company in a report on Friday, September 26th. Guggenheim increased their price target on shares of Accenture from $285.00 to $305.00 and gave the company a “buy” rating in a research note on Monday. Wells Fargo & Company started coverage on shares of Accenture in a research note on Tuesday, October 21st. They set an “equal weight” rating and a $251.00 price objective on the stock. Stifel Nicolaus cut their target price on shares of Accenture from $355.00 to $315.00 and set a “buy” rating for the company in a research note on Tuesday, September 16th. Finally, Evercore ISI reissued an “outperform” rating and set a $300.00 price target on shares of Accenture in a research report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Accenture has an average rating of “Moderate Buy” and an average price target of $296.75.
Get Our Latest Report on Accenture
Accenture Company Profile
Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.
See Also
- Five stocks we like better than Accenture
- Election Stocks: How Elections Affect the Stock Market
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- Best Stocks Under $5.00
- Forget the Chips: 4 Industrial Plays for the AI Rebound
- The 3 Best Blue-Chip Stocks to Buy Now
- MongoDB Could Hit Record Highs—But You’ll Need to Move Fast
Want to see what other hedge funds are holding ACN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accenture PLC (NYSE:ACN – Free Report).
Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.
